These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3541501)

  • 1. Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
    Ahonen P; Myllärniemi S; Kahanpää A; Perheentupa J
    Acta Med Scand; 1986; 220(4):333-9. PubMed ID: 3541501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (APECED): autosomal recessive inheritance.
    Ahonen P
    Clin Genet; 1985 Jun; 27(6):535-42. PubMed ID: 4017274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.
    Petersen EA; Alling DW; Kirkpatrick CH
    Ann Intern Med; 1980 Dec; 93(6):791-5. PubMed ID: 6255844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
    Mobacken H; Moberg S
    Dermatologica; 1986; 173(5):229-36. PubMed ID: 3100354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge.
    Jääskeläinen J; Perheentupa J
    Pediatr Endocrinol Rev; 2009 Dec; 7(2):15-28. PubMed ID: 20118890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic mucocutaneous candidosis with ketoconazole: preliminary results of a controlled, double-blind clinical trial.
    Kirkpatrick CH; Petersen EA; Alling DW
    Rev Infect Dis; 1980; 2(4):599. PubMed ID: 6255538
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases.
    Hay RJ; Wells RS; Clayton YM; Wingfield HJ
    Rev Infect Dis; 1980; 2(4):600-5. PubMed ID: 6255539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole.
    Drouhet E; Dupont B
    Rev Infect Dis; 1980; 2(4):606-19. PubMed ID: 6255540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
    Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
    Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
    Appleboom TM; Flowers FP
    Cutis; 1982 Jul; 30(1):71-2. PubMed ID: 6288325
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketoconazole in a case of chronic mucocutaneous candidiasis.
    Zachariae H; Laurberg G; Thestrup-Pedersen K
    Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole.
    Hay RJ; Clayton YM
    Clin Exp Dermatol; 1982 Mar; 7(2):155-62. PubMed ID: 6282505
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis.
    Roberton DM; Hosking CS
    Aust Paediatr J; 1983 Sep; 19(3):178-81. PubMed ID: 6316890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment of skin candidosis: a randomized comparison of terbinafine and ketoconazole.
    Jung EG; Haas PJ; Bräutigam M; Weidinger G
    Mycoses; 1994; 37(9-10):361-5. PubMed ID: 7746297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Graybill JR; Herndon JH; Kniker WT; Levine HB
    Arch Dermatol; 1980 Oct; 116(10):1137-41. PubMed ID: 6252853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
    Fanconi S; Seger R; Joller P; Issler C; Schär G
    Eur J Pediatr; 1982 Nov; 139(3):176-80. PubMed ID: 6297913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
    Proto G; Leoni S; Torossi I; Mazzolini A; Grimaldi F; Bertolissi F
    Minerva Med; 1992; 83(7-8):475-8. PubMed ID: 1522973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
    Daugaard K; Nielsen H; Schiodt M
    Tandlaegebladet; 1985 Oct; 89(18):674-8. PubMed ID: 3868177
    [No Abstract]   [Full Text] [Related]  

  • 20. Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
    Smith DE; Midgley J; Allan M; Connolly GM; Gazzard BG
    AIDS; 1991 Nov; 5(11):1367-71. PubMed ID: 1662959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.